Dendrimers for Sustained Release of Compounds

Dendrimer-based compositions and methods are provided, that are useful for administering pharmaceutical compositions to target cells and tissues for treatment of ocular diseases including macular degeneration, diabetic retinopathy, and retinitis pigmentosa.

Attached files:
US 20110034422.jpg

Patents:
US 20,110,034,422

Inventor(s): KANNAN RANGARAMANUJAM [US]; IEZZI RAYMOND [US]; RAJAGURU BHARATH [US]; KANNAN SUJATHA [US]

Type of Offer: Licensing



Next Patent »
« More Pharmaceutical Patents

Share on      


CrowdSell Your Patent